Apriem Advisors’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-500
Closed -$12K 167
2018
Q2
$12K Buy
+500
New +$10.3K ﹤0.01% 397
2017
Q2
Sell
-700
Closed -$8K 180
2017
Q1
$8K Hold
700
﹤0.01% 432
2016
Q4
$10K Hold
700
﹤0.01% 438
2016
Q3
$17K Sell
700
-75
-10% -$1.94K 0.01% 346
2016
Q2
$16K Hold
775
0.01% 361
2016
Q1
$20K Buy
775
+475
+158% +$35.1K 0.01% 307
2015
Q4
$30K Buy
300
+200
+200% +$22.5K 0.01% 246
2015
Q3
$18K Hold
100
0.01% 305
2015
Q2
$22K Sell
100
-100
-50% -$22.2K 0.01% 307
2015
Q1
$40K Buy
200
+100
+100% +$17.7K 0.01% 225
2014
Q4
$14K Hold
100
0.01% 340
2014
Q3
$13K Buy
+100
New +$11.9K 0.01% 349
2014
Q2
Sell
-100
Closed -$12.8K 482
2014
Q1
$13K Hold
100
﹤0.01% 335
2013
Q4
$12K Hold
100
﹤0.01% 338
2013
Q3
$10K Hold
100
﹤0.01% 351
2013
Q2
$9K Buy
+100
New +$7.88K ﹤0.01% 337

Other funds holding BHC

Apriem Advisors's BHC Position: Q3 2018 in Review

Apriem Advisors sold out of Bausch Health (BHC) in Q3 2018, closing a stake of 500 shares — an estimated $12K sold.

Apriem Advisors first reported a position in BHC in Q2 2013 and held it in 16 quarters. The position peaked at $40K in Q1 2015. 332 funds tracked by Wall St. Rank hold BHC as of Q3 2018.

  • Apriem Advisors reported no remaining Bausch Health position as of Q3 2018 after selling out during the quarter.
  • Apriem Advisors sold 500 Bausch Health shares in Q3 2018, an estimated $12K.
  • Apriem Advisors first reported a position in Bausch Health in Q2 2013 and held it in 16 quarters.
  • Apriem Advisors's Bausch Health position peaked at $40K in Q1 2015.
  • 332 funds tracked by Wall St. Rank held Bausch Health as of Q3 2018.

Based on Apriem Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.